In this issue:
Novel evidence-based classification of cavernous venous occlusive disease
5-ARIs and EF/sexual function
Patients’ sexual function expectations following radical prostatectomy
Lifestyle factors and PE
Triglycerides predict ED and major CV events in sexual dysfunction
Tadalafil trial data models identify EF recovery predictors postradical prostatectomy
Testosterone level for type 2 diabetes risk assessment
Australian position statement on male hypogonadism
PDE-5 inhibitors and prostate cancer
Mediterranean diet prevents sexual dysfunction in type 2 diabetes
Please login below to download this issue (PDF)